Shilpa Begur Shivakumar, MD

Carla West Roberts, MD is a highly-rated pediatric hematologist-oncologist based in Columbia, SC. With extensive training from reputable institutions such as the Medical University of South Carolina and Emory University Hospital, Dr. Roberts provides expert care to infants, toddlers, children, and teens with hematological and oncological conditions. Patients appreciate the welcoming environment and exceptional staff at Prisma Health Pediatric Hematology Oncology, where Dr. Roberts practices. As a board-certified specialist in pediatric hematology-oncology, Dr. Carla West Roberts offers compassionate and comprehensive care to her patients in Columbia, SC. With a focus on sickle cell disease and other blood disorders, Dr. Roberts utilizes her expertise gained from her fellowship at the University of Virginia Health System to provide the highest quality of care. Patients and their families can trust in Dr. Roberts' dedication and experience in the field of pediatric hematology-oncology.Generated from the website

Stephanie Phillips Ambrose, DO, received her medical degree from the Edward Via Virginia College of Osteopathic Medicine in Blacksburg. She completed her residency in pediatrics at Palmetto Health Children’s Hospital in Columbia, South Carolina, and her fellowship in pediatric hematology-oncology at the Medical University of South Carolina in Charleston.

Stuart Cramer, DO, joined Prisma Health in 2017 as the medical director of the Children's Center for Cancer and Blood Disorders. Originally from Florida, he received his medical degree at Nova Southeastern University College of Osteopathic Medicine and completed his pediatric hematology/oncology fellowship at the University of Alabama Children’s Hospital in Birmingham, where he was the director of developmental therapeutics. As part of his honors thesis while in college, Dr. Cramer pursued three years of scientific research, which provoked his appreciation of merging basic science with clinical medicine. His fellowship training solidified his interest in cancer cell biology, and afforded him the opportunity to expand his research experience focusing on novel therapeutics. With his research background, he has developed a broad knowledge of drug resistance within pediatric solid tumors and the role of novel therapeutics in the treatment of pediatric solid tumors. Cramer’s current focus is on developing a therapeutics program based in Columbia, enabling pediatric patients access to novel therapies developed both nationally and locally.